Page last updated: 2024-10-27

flufenamic acid and Osteogenic Sarcoma

flufenamic acid has been researched along with Osteogenic Sarcoma in 2 studies

Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Passeri, G1
Northcote-Smith, J1
Perera, R1
Gubic, N1
Suntharalingam, K1
Rodan, SB1
Rodan, GA1
Simmons, HA1
Walenga, RW1
Feinstein, MB1
Raisz, LG1

Other Studies

2 other studies available for flufenamic acid and Osteogenic Sarcoma

ArticleYear
An Osteosarcoma Stem Cell Potent Nickel(II)-Polypyridyl Complex Containing Flufenamic Acid.
    Molecules (Basel, Switzerland), 2022, May-19, Volume: 27, Issue:10

    Topics: Bone Neoplasms; Cell Line, Tumor; Coordination Complexes; Cyclooxygenase 2; Flufenamic Acid; Humans;

2022
Bone resorptive factor produced by osteosarcoma cells with osteoblastic features is PGE2.
    Biochemical and biophysical research communications, 1981, Oct-30, Volume: 102, Issue:4

    Topics: Animals; Bone Neoplasms; Bone Resorption; Cell Line; Chromatography, Thin Layer; Culture Media; Dino

1981